Abstract

Transverse myelitis (TM) includes a pathobiologically heterogeneous syndrome characterized by acute or subacute spinal cord dysfunction resulting in paresis, a sensory level, and autonomic (bladder, bowel, and sexual) impairment below the level of the lesion. Etiologies for TM can be broadly classified as parainfectious, paraneoplastic, drug/toxin-induced, systemic autoimmune disorders, and acquired demyelinating diseases. We discuss the clinical evaluation, workup, and acute and long-term management of patients with TM. Additionally, we briefly discuss various disease entities that may cause TM and their salient distinguishing features, as well as disorders that may mimic TM.

Original languageEnglish (US)
Pages (from-to)79-138
Number of pages60
JournalNeurologic Clinics
Volume31
Issue number1
DOIs
StatePublished - Feb 2013

Fingerprint

Transverse Myelitis
Demyelinating Diseases
Paresis
Spinal Cord
Urinary Bladder
Pharmaceutical Preparations

Keywords

  • Idiopathic transverse myelitis
  • Longitudinally-extensive transverse myelitis
  • Lupus myelopathy
  • Multiple sclerosis
  • Sjogren's myelopathy
  • Transverse myelitis

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Transverse Myelitis. / Beh, Shin C; Greenberg, Benjamin; Frohman, Teresa; Frohman, Elliot.

In: Neurologic Clinics, Vol. 31, No. 1, 02.2013, p. 79-138.

Research output: Contribution to journalArticle

Beh, Shin C ; Greenberg, Benjamin ; Frohman, Teresa ; Frohman, Elliot. / Transverse Myelitis. In: Neurologic Clinics. 2013 ; Vol. 31, No. 1. pp. 79-138.
@article{9d466dd14a9a4000bf22085302971529,
title = "Transverse Myelitis",
abstract = "Transverse myelitis (TM) includes a pathobiologically heterogeneous syndrome characterized by acute or subacute spinal cord dysfunction resulting in paresis, a sensory level, and autonomic (bladder, bowel, and sexual) impairment below the level of the lesion. Etiologies for TM can be broadly classified as parainfectious, paraneoplastic, drug/toxin-induced, systemic autoimmune disorders, and acquired demyelinating diseases. We discuss the clinical evaluation, workup, and acute and long-term management of patients with TM. Additionally, we briefly discuss various disease entities that may cause TM and their salient distinguishing features, as well as disorders that may mimic TM.",
keywords = "Idiopathic transverse myelitis, Longitudinally-extensive transverse myelitis, Lupus myelopathy, Multiple sclerosis, Sjogren's myelopathy, Transverse myelitis",
author = "Beh, {Shin C} and Benjamin Greenberg and Teresa Frohman and Elliot Frohman",
year = "2013",
month = "2",
doi = "10.1016/j.ncl.2012.09.008",
language = "English (US)",
volume = "31",
pages = "79--138",
journal = "Neurologic Clinics",
issn = "0733-8619",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Transverse Myelitis

AU - Beh, Shin C

AU - Greenberg, Benjamin

AU - Frohman, Teresa

AU - Frohman, Elliot

PY - 2013/2

Y1 - 2013/2

N2 - Transverse myelitis (TM) includes a pathobiologically heterogeneous syndrome characterized by acute or subacute spinal cord dysfunction resulting in paresis, a sensory level, and autonomic (bladder, bowel, and sexual) impairment below the level of the lesion. Etiologies for TM can be broadly classified as parainfectious, paraneoplastic, drug/toxin-induced, systemic autoimmune disorders, and acquired demyelinating diseases. We discuss the clinical evaluation, workup, and acute and long-term management of patients with TM. Additionally, we briefly discuss various disease entities that may cause TM and their salient distinguishing features, as well as disorders that may mimic TM.

AB - Transverse myelitis (TM) includes a pathobiologically heterogeneous syndrome characterized by acute or subacute spinal cord dysfunction resulting in paresis, a sensory level, and autonomic (bladder, bowel, and sexual) impairment below the level of the lesion. Etiologies for TM can be broadly classified as parainfectious, paraneoplastic, drug/toxin-induced, systemic autoimmune disorders, and acquired demyelinating diseases. We discuss the clinical evaluation, workup, and acute and long-term management of patients with TM. Additionally, we briefly discuss various disease entities that may cause TM and their salient distinguishing features, as well as disorders that may mimic TM.

KW - Idiopathic transverse myelitis

KW - Longitudinally-extensive transverse myelitis

KW - Lupus myelopathy

KW - Multiple sclerosis

KW - Sjogren's myelopathy

KW - Transverse myelitis

UR - http://www.scopus.com/inward/record.url?scp=84870163983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870163983&partnerID=8YFLogxK

U2 - 10.1016/j.ncl.2012.09.008

DO - 10.1016/j.ncl.2012.09.008

M3 - Article

C2 - 23186897

AN - SCOPUS:84870163983

VL - 31

SP - 79

EP - 138

JO - Neurologic Clinics

JF - Neurologic Clinics

SN - 0733-8619

IS - 1

ER -